Albemarle's earnings have been declining at an average annual rate of -33.8%, while the Chemicals industry saw earnings growing at 8% annually. Revenues have been growing at an average rate of 7.1% per year.
Key information
-33.80%
Earnings growth rate
-33.98%
EPS growth rate
Chemicals Industry Growth
23.20%
Revenue growth rate
7.13%
Return on equity
-1.84%
Net Margin
-7.27%
Last Earnings Update
31 Mar 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Albemarle makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
BIT:1ALB Revenue, expenses and earnings (USD Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
5,495
-400
559
46
31 Dec 25
5,143
-677
543
51
30 Sep 25
4,946
-188
503
59
30 Jun 25
4,993
-1,096
523
69
31 Mar 25
5,094
-1,307
558
77
31 Dec 24
5,378
-1,316
595
87
30 Sep 24
6,502
-1,967
647
89
30 Jun 24
7,458
-554
655
88
31 Mar 24
8,398
326
654
89
31 Dec 23
9,617
1,573
869
86
30 Sep 23
9,882
3,324
570
83
30 Jun 23
9,663
3,918
532
80
31 Mar 23
8,773
3,675
483
76
31 Dec 22
7,320
2,690
439
72
30 Sep 22
5,593
1,554
393
64
30 Jun 22
4,332
264
365
59
31 Mar 22
3,626
281
363
55
31 Dec 21
3,328
124
333
54
30 Sep 21
3,313
212
450
57
30 Jun 21
3,229
703
439
58
31 Mar 21
3,219
364
418
58
31 Dec 20
3,129
376
427
59
30 Sep 20
3,242
382
411
58
30 Jun 20
3,375
438
430
60
31 Mar 20
3,496
507
453
59
31 Dec 19
3,589
533
470
58
30 Sep 19
3,519
572
440
60
30 Jun 19
3,417
547
432
61
31 Mar 19
3,385
695
417
64
31 Dec 18
3,375
694
415
70
30 Sep 18
3,311
346
410
75
30 Jun 18
3,288
335
416
80
31 Mar 18
3,172
135
421
81
31 Dec 17
3,072
55
420
79
30 Sep 17
2,911
315
431
77
30 Jun 17
2,810
302
416
75
31 Mar 17
2,742
282
396
78
31 Dec 16
2,677
442
355
79
30 Sep 16
2,703
560
303
82
30 Jun 16
2,742
510
297
84
31 Mar 16
2,791
468
299
86
31 Dec 15
2,826
302
300
89
30 Sep 15
2,702
124
397
89
30 Jun 15
2,652
149
382
89
Quality Earnings: 1ALB is currently unprofitable.
Growing Profit Margin: 1ALB is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1ALB is unprofitable, and losses have increased over the past 5 years at a rate of 33.8% per year.
Accelerating Growth: Unable to compare 1ALB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 1ALB is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-36.9%).
Return on Equity
High ROE: 1ALB has a negative Return on Equity (-1.84%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/05/15 21:17
End of Day Share Price
2026/05/15 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Albemarle Corporation is covered by 37 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.